Samuel Legeay

950 total citations
31 papers, 682 citations indexed

About

Samuel Legeay is a scholar working on Molecular Biology, Biomaterials and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Samuel Legeay has authored 31 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Biomaterials and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Samuel Legeay's work include Nanoparticle-Based Drug Delivery (6 papers), Protein Interaction Studies and Fluorescence Analysis (4 papers) and Lipid Membrane Structure and Behavior (4 papers). Samuel Legeay is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Protein Interaction Studies and Fluorescence Analysis (4 papers) and Lipid Membrane Structure and Behavior (4 papers). Samuel Legeay collaborates with scholars based in France, United States and Canada. Samuel Legeay's co-authors include Sébastien Faure, Nicolas Clere, Marion Rodier, Emilie Roger, Bruno Lapied, Véronique Apaire-Marchais, Patrick Saulnier, Frédéric Lagarce, Jérôme Bejaud and Grégory Hilairet and has published in prestigious journals such as Macromolecules, Scientific Reports and Brain Research.

In The Last Decade

Samuel Legeay

26 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Legeay France 11 164 124 109 72 69 31 682
Barbara Bobrowska‐Korczak Poland 15 191 1.2× 68 0.5× 102 0.9× 46 0.6× 56 0.8× 62 788
Longying Zha China 20 354 2.2× 82 0.7× 158 1.4× 112 1.6× 85 1.2× 44 1.0k
Mohammad Kashif Iqubal India 17 316 1.9× 90 0.7× 61 0.6× 30 0.4× 90 1.3× 44 1.2k
Abolfazl Akbari Iran 20 124 0.8× 64 0.5× 99 0.9× 62 0.9× 92 1.3× 54 869
Mohd Salim Reshi India 12 267 1.6× 69 0.6× 87 0.8× 58 0.8× 104 1.5× 27 971
Nadia Z. Shaban Egypt 16 173 1.1× 51 0.4× 63 0.6× 65 0.9× 31 0.4× 39 734
Manal Abudawood Saudi Arabia 16 192 1.2× 43 0.3× 78 0.7× 39 0.5× 75 1.1× 55 903
Ramazan Uygur Türkiye 13 104 0.6× 58 0.5× 85 0.8× 28 0.4× 45 0.7× 23 653
Tomáš Roušar Czechia 18 338 2.1× 92 0.7× 57 0.5× 54 0.8× 141 2.0× 60 1.3k
Mazen M. Ghaith Saudi Arabia 13 127 0.8× 62 0.5× 79 0.7× 23 0.3× 40 0.6× 33 663

Countries citing papers authored by Samuel Legeay

Since Specialization
Citations

This map shows the geographic impact of Samuel Legeay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Legeay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Legeay more than expected).

Fields of papers citing papers by Samuel Legeay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Legeay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Legeay. The network helps show where Samuel Legeay may publish in the future.

Co-authorship network of co-authors of Samuel Legeay

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Legeay. A scholar is included among the top collaborators of Samuel Legeay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Legeay. Samuel Legeay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chaslerie, Anicet, et al.. (2024). Association between Pandemic of COVID‐19 and Influenza Vaccine Take‐Up in 2020–2021 in Maine et Loire (France). Journal of Clinical Pharmacy and Therapeutics. 2024(1).
3.
Legeay, Samuel, et al.. (2024). The dichotomous activities of microglia: A potential driver for phenotypic heterogeneity in Alzheimer’s disease. Brain Research. 1832. 148817–148817. 5 indexed citations
4.
Fabre, T., Samuel Legeay, Guillaume Bastiat, et al.. (2024). Investigating the Reactivity of a Novel Methacrylic Transmer in Solution RAFT-SCVP and Its Impact on the Structure of the Resulting Hyperbranched Polymers. Macromolecules. 57(5). 2421–2431. 5 indexed citations
5.
Li, Ling, et al.. (2024). Moving towards the implementation of pharmacogenetic testing in Quebec. Frontiers in Genetics. 14. 1295963–1295963. 2 indexed citations
6.
Hilairet, Grégory, Jérôme Bejaud, Patrick Saulnier, et al.. (2022). Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique. Journal of Controlled Release. 351. 681–691. 16 indexed citations
7.
Legeay, Samuel, et al.. (2022). FRET as the tool for in vivo nanomedicine tracking. Journal of Controlled Release. 349. 156–173. 41 indexed citations
8.
Legeay, Samuel, et al.. (2022). Effects of students’ peer teaching in a new pharmacokinetics teaching format. Annales Pharmaceutiques Françaises. 81(2). 248–257.
9.
Franconi, Florence, et al.. (2021). Organic Nanoparticle Tracking During Pharmacokinetic Studies. Nanomedicine. 16(28). 2539–2536. 7 indexed citations
10.
Bejaud, Jérôme, Nolwenn Lautram, Florence Manero, et al.. (2021). New In Vitro Coculture Model for Evaluating Intestinal Absorption of Different Lipid Nanocapsules. Pharmaceutics. 13(5). 595–595. 8 indexed citations
11.
Legeay, Samuel, et al.. (2021). Specificity of pharmacokinetic modeling of nanomedicines. Drug Discovery Today. 26(10). 2259–2268. 16 indexed citations
12.
Foudi, Nabil & Samuel Legeay. (2021). Effects of physical activity on cell‐to‐cell communication during type 2 diabetes: A focus on miRNA signaling. Fundamental and Clinical Pharmacology. 35(5). 808–821. 6 indexed citations
13.
Legeay, Samuel, et al.. (2020). Novel Insights into the Mode of Action of Vasorelaxant Synthetic Polyoxygenated Chalcones. International Journal of Molecular Sciences. 21(5). 1609–1609. 3 indexed citations
14.
Legeay, Samuel, Galina Antonova, Simone Kennard, et al.. (2020). Selective deficiency in endothelial PTP1B protects from diabetes and endoplasmic reticulum stress-associated endothelial dysfunction via preventing endothelial cell apoptosis. Biomedicine & Pharmacotherapy. 127. 110200–110200. 18 indexed citations
15.
Legeay, Samuel, Emmanuelle Bichon, Ingrid Guiffard, et al.. (2019). In vivo comparison of the proangiogenic properties of chlordecone and three of its dechlorinated derivatives formed by in situ chemical reduction. Environmental Science and Pollution Research. 27(33). 40953–40962. 4 indexed citations
16.
Roger, Emilie, Jérôme Bejaud, Nolwenn Lautram, et al.. (2019). <p>Di-<em>O</em>-lauroyl-decitabine-lipid nanocapsules: toward extending decitabine activity</p>. International Journal of Nanomedicine. Volume 14. 2091–2102. 5 indexed citations
17.
18.
Legeay, Samuel & Sébastien Faure. (2017). Is bisphenol A an environmental obesogen?. Fundamental and Clinical Pharmacology. 31(6). 594–609. 99 indexed citations
19.
Legeay, Samuel, Nicolas Clere, Grégory Hilairet, et al.. (2016). The insect repellent N,N-diethyl-m-toluamide (DEET) induces angiogenesis via allosteric modulation of the M3 muscarinic receptor in endothelial cells. Scientific Reports. 6(1). 28546–28546. 25 indexed citations
20.
Legeay, Samuel, et al.. (2015). Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome. Nutrients. 7(7). 5443–5468. 267 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Bobrowska‐Korczak Breakdown of academic impact, for papers by Longying Zha Breakdown of academic impact, for papers by Mohammad Kashif Iqubal Breakdown of academic impact, for papers by Abolfazl Akbari Breakdown of academic impact, for papers by Mohd Salim Reshi Breakdown of academic impact, for papers by Nadia Z. Shaban Breakdown of academic impact, for papers by Manal Abudawood Breakdown of academic impact, for papers by Ramazan Uygur Breakdown of academic impact, for papers by Tomáš Roušar Breakdown of academic impact, for papers by Mazen M. Ghaith
Rankless by CCL
2026